← all signals · sectors · research

KYNTRA BIO, INC. KYNB

SIC 2834 — Pharmaceutical Preparations · CIK 921299

This page lists every Interactive Market Data signal that fired on this company across fiscal years, with the calibrated net-of-cost forward-return prediction. Predictions use a triple → pair → singles fallback against our backtest panel (~32K (cik × fy) signal combos, net of execution costs at 5 bps half-spread + ADV-tiered borrow).

FY2025 short

1 signal fired · match: singles_avg

dso_drift_severe

HorizonPredicted net PnL
20 days-2.54%
60 days-11.34%
252 days (1y)-24.65%

FY2023 short

1 signal fired · match: singles_avg

capex_spike

HorizonPredicted net PnL
20 days+2.05%
60 days-0.78%
252 days (1y)-14.91%

FY2022 short

1 signal fired · match: singles_avg

dso_drift_severe

HorizonPredicted net PnL
20 days-2.54%
60 days-11.34%
252 days (1y)-24.65%

FY2021 short

1 signal fired · match: singles_avg

fcf_turn_negative

HorizonPredicted net PnL
20 days+1.36%
60 days-1.61%
252 days (1y)-16.85%

FY2020 long

2 signals fired · match: pair

dso_drift_severe, fcf_turn_positive

HorizonPredicted net PnL
20 days+0.69%
60 days+1.62%
252 days (1y)+6.76%

FY2017 short

2 signals fired · match: pair

capex_spike, fcf_turn_negative

HorizonPredicted net PnL
20 days+2.92%
60 days+1.26%
252 days (1y)-2.11%

Methodology: /methodology · Live JSON: /api/company/921299/financials